Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Åsne Jul-Larsen"'
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-6 (2021)
Abstract Current influenza vaccines have a suboptimal effectiveness. The introduction of a novel A/H1N1 influenza virus in 2009 (H1N1pdm09) provided a unique opportunity to study the humoral response to the AS03-adjuvanted H1N1pdm09 vaccine and repea
Externí odkaz:
https://doaj.org/article/289f3ecc96424a40be207c2772ea704a
Autor:
Kristin G-I Mohn, Rebecca Jane Cox, Gro Tunheim, Jan Erik Berdal, Anna Germundsson Hauge, Åsne Jul-Larsen, Norwegian Pandemic Group, Bjoern Peters, Fredrik Oftung, Christine Monceyron Jonassen, Siri Mjaaland
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0143281 (2015)
Increased understanding of immune responses influencing clinical severity during pandemic influenza infection is important for improved treatment and vaccine development. In this study we recruited 46 adult patients during the 2009 influenza pandemic
Externí odkaz:
https://doaj.org/article/42885cca4c1c4920a03104fef998b2f4
Publikováno v:
NPJ Vaccines
npj Vaccines
npj Vaccines, Vol 6, Iss 1, Pp 1-6 (2021)
npj Vaccines
npj Vaccines, Vol 6, Iss 1, Pp 1-6 (2021)
Current influenza vaccines have a suboptimal effectiveness. The introduction of a novel A/H1N1 influenza virus in 2009 (H1N1pdm09) provided a unique opportunity to study the humoral response to the AS03-adjuvanted H1N1pdm09 vaccine and repeated annua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3433b9705224fe0ca07bb412389c3e0
https://pubmed.ncbi.nlm.nih.gov/33795694
https://pubmed.ncbi.nlm.nih.gov/33795694
Autor:
Anders Madsen, Steinar Skrede, Rebecca Jane Cox, Åsne Jul-Larsen, Mai-Chi Trieu, Marianne Sævik, Jane Kristin Nøstbakken, Fan Zhou
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The 2009 influenza pandemic was caused by the A/H1N1pdm09 virus, which was subsequently included in the seasonal vaccine, up to 2016/2017, as the A/H1N1 strain. This provided a unique opportunity to investigate the antibody response to H1N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08454dbd33033d71c643e69ac40f56ae
https://doi.org/10.1093/cid/ciy487
https://doi.org/10.1093/cid/ciy487
Autor:
Christian A. Vedeler, Sarah Lartey, Åsne Jul-Larsen, Henning K. Olberg, Geir Egil Eide, Kjell-Morten Myhr, Rebecca Jane Cox
Publikováno v:
European Journal of Neurology. 25:527-534
Background and purpose We have previously shown that patients with multiple sclerosis receiving immunomodulatory treatment have reduced seroprotection rates after influenza immunization. The aim of this study was to further investigate the influence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e075bec3636a0b119635871f2f73b9f
https://doi.org/10.1111/ene.13537
https://doi.org/10.1111/ene.13537
Autor:
Anders Madsen, Florian Krammer, Åsne Jul-Larsen, Linda Azimi, Fan Zhou, Rebecca Jane Cox, Sarah M. Tete
Publikováno v:
Vaccine: X, Vol 2, Iss, Pp-(2019)
Vaccine: X
Vaccine: X
Highlights • AS03-adjuvanted H1N1pdm09 vaccine elicited robust antibody responses. • More antigenically experienced individuals had higher pre-vaccination HA stalk specific antibodies. • AS03 adjuvanted H1N1pdm09 vaccine overcomes problems of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f286900faf985a27db15da34f57f95
http://www.sciencedirect.com/science/article/pii/S2590136219300300
http://www.sciencedirect.com/science/article/pii/S2590136219300300
Autor:
Åsne Jul-Larsen, Jon A. Hardie, Rebecca Jane Cox, Thomas Blix Grydeland, Tomas Mikal Eagan, Per Bakke
Publikováno v:
Europe PubMed Central
Background COPD patients are advised vaccination against seasonal influenza, yet few studies have evaluated the protective antibody titers obtained in this patient group. Aims 1) To describe protective titers in COPD patients who self-reported influe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945fcbfa045a2b29f8f00f7968a13888
https://doi.org/10.1016/j.rmed.2016.04.008
https://doi.org/10.1016/j.rmed.2016.04.008
Autor:
Synnøve Eidem, Åsne Jul-Larsen, Katja Hoschler, Rebecca Jane Cox, Sarah M. Tete, Emanuele Montomoli, Karl A. Brokstad
Publikováno v:
Vaccine. 33:4146-4154
Healthcare workers are at increased risk of influenza infection through direct patient care, particularly during the early stages of a pandemic. Although influenza vaccination is widely recommended in Healthcare workers, data on long-term immunogenic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6556bc53e53ba39f28b31a15e79c368d
https://doi.org/10.1016/j.vaccine.2015.05.081
https://doi.org/10.1016/j.vaccine.2015.05.081
Autor:
Åsne Jul-Larsen, Rebecca Jane Cox
Publikováno v:
Current Issues with Influenza Management. :110-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fffc3d10da2b952829ddd16641134b3f
https://doi.org/10.2217/fmeb2013.13.222
https://doi.org/10.2217/fmeb2013.13.222
Autor:
John Wood, Rebecca Jane Cox, Åsne Jul-Larsen, Rishi D. Pathirana, Emanuele Montomoli, Sarah Lartey, Fan Zhou
Publikováno v:
Human Vaccines & Immunotherapeutics
Healthcare workers (HCW) were prioritized for vaccination during the 2009 influenza A(H1N1)pdm09 pandemic. We conducted a clinical trial in October 2009 where 237 HCWs were immunized with a AS03-adjuvanted A(H1N1)pdm09 monovalent vaccine. In the curr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4879d0775353dbee57921a2ce5c28bd
http://europepmc.org/articles/PMC4514283
http://europepmc.org/articles/PMC4514283